retatrutide week 2 phase trial type 2 diabetes is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with Retatrutide for weight loss: Study
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


























